Danking Pharmaceuticals
Beijing
About Danking Pharmaceuticals
Danatlas is a pharmaceutical company that develops drugs designed for oncology treatment. It also provides drug research and development in the fields of cancer, inflammation, blood, and metabolic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $20.6M
- Funding stage: Seed
- Last round: Seed (Mar 2025)
- Website: danatlas.com
- Phone: 010-6780-3200
Industries & Categories
Biopharma, Health Care, Medical
Canonical: https://fsome.com/organization/danking-pharmaceuticals-6463 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.